OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2024
(7)
2025
(6)
2023
(5)
2020
(3)
2022
(1)
2019
(1)
2018
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Modulation of electronic and magnetic properties of defective and TM-doped Al<sub>2</sub>SSe Janus monolayer (TM = Mn and Fe) through hole and electron doping.
Not available
S-EPMC12716252
|
biostudies-literature
Cite
A new species of
Gracixalus
(Anura, Rhacophoridae) from northwestern Vietnam.
Not available
S-EPMC10208806
|
biostudies-literature
Cite
PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Not available
S-EPMC6423417
|
biostudies-literature
Cite
Effectiveness of a Smartphone-Based Stress Management Program for Depression in Hospital Nurses During COVID-19 in Vietnam and Thailand: 2-Arm Parallel-Group Randomized Controlled Trial.
Not available
S-EPMC11399744
|
biostudies-literature
Cite
Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor.
Not available
S-EPMC10731702
|
biostudies-literature
Cite
Association of Weather Variables With Pathogens Contributing to Conjunctivitis Worldwide.
Not available
S-EPMC11912971
|
biostudies-literature
Cite
Determinants of antibiotic prescribing in primary care in Vietnam: a qualitative study using the Theoretical Domains Framework.
Not available
S-EPMC11443765
|
biostudies-literature
Cite
Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors.
Not available
S-EPMC7140067
|
biostudies-literature
Cite
A mouse model for hemoglobin SC disease recapitulates characteristic human pathologies.
Not available
S-EPMC12745012
|
biostudies-literature
Cite
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.
Not available
S-EPMC9982342
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets